RhumbLine Advisers
DTIL icon

RhumbLine Advisers’s Precision BioSciences DTIL Stock Holding History

RhumbLine Advisers’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
27,864
+27,589
+10,032% +$194K ﹤0.01% 3239
2026
Q1 		$1.51K Hold
275
– – ﹤0.01% 3957
2025
Q4 		$1.14K Hold
275
– – ﹤0.01% 4025
2025
Q3 		$1.52K Hold
275
– – ﹤0.01% 4006
2025
Q2 		$1.16K Hold
275
– – ﹤0.01% 4029
2025
Q1 		$1.31K Hold
275
– – ﹤0.01% 4011
2024
Q4 		$1.05K Hold
275
– – ﹤0.01% 4075
2024
Q3 		$2.46K Buy
+275
New +$2.65K ﹤0.01% 4049
2022
Q2 		– Sell
-1,655
Closed -$153K – 3136
2022
Q1 		$153K Buy
1,655
+73
+5% +$9.92K ﹤0.01% 2813
2021
Q4 		$351K Sell
1,582
-24
-1% -$6.7K ﹤0.01% 2656
2021
Q3 		$556K Buy
1,606
+78
+5% +$26.4K ﹤0.01% 2501
2021
Q2 		$574K Sell
1,528
-118
-7% -$35.4K ﹤0.01% 2504
2021
Q1 		$511K Sell
1,646
-76
-4% -$26.6K ﹤0.01% 2481
2020
Q4 		$431K Buy
1,722
+160
+10% +$39.2K ﹤0.01% 2497
2020
Q3 		$289K Sell
1,562
-176
-10% -$35K ﹤0.01% 2535
2020
Q2 		$434K Buy
1,738
+502
+41% +$110K ﹤0.01% 2413
2020
Q1 		$224K Buy
1,236
+93
+8% +$24.3K ﹤0.01% 2536
2019
Q4 		$476K Buy
+1,143
New +$359K ﹤0.01% 2381

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

RhumbLine Advisers's DTIL Position: Q2 2026 in Review

RhumbLine Advisers increased its Precision BioSciences (DTIL) stake by 10,032% in Q2 2026, buying an estimated $194K and bringing the position to 27,864 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #3239.

RhumbLine Advisers first reported a position in DTIL in Q4 2019 and has held it in 18 quarters since. The position peaked at $574K in Q2 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • RhumbLine Advisers held 27,864 shares of Precision BioSciences worth $219K as of Q2 2026.
  • RhumbLine Advisers bought 27,589 Precision BioSciences shares in Q2 2026, an estimated $194K.
  • Precision BioSciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3239 holding.
  • RhumbLine Advisers first reported a position in Precision BioSciences in Q4 2019 and has held it in 18 quarters since.
  • RhumbLine Advisers's Precision BioSciences position peaked at $574K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.